Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Generic Drug, Supreme Court

Digest more
Top News
Overview
 · 1d
Supreme Court Protects ‘Skinny Label’ Generic Drug Pathway (2)
The Supreme Court said a district court judge was right to dismiss Amarin Pharma Inc.'s infringement suit over claims its competitor encouraged doctors to prescribe its generic heart health drug for a treatment method covered by active Amarin patents.

Continue reading

 · 14h
Generic drugmakers gain key victory in ‘skinny label’ patent case
 · 1d · on MSN
US Supreme Court backs generic drugmaker in 'skinny label' patent case
 · 9h
Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products
The opinion of Justice Ketanji Brown Jackson for a unanimous court rejected the idea that a generics pharmaceutical manufacturer (Hikma) can be held responsible for infringements of patents held by th...

Continue reading

Pharm Exec · 13h
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
 · 1d
Justice Jackson Pens Unanimous Decision Backed by SCOTUS Conservatives
JD Supra
2y

DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information

In June 2023, the U.S. Food and Drug Administration (FDA) published final guidance (Guidance) on presenting risk and efficacy information for direct-to-consumer (DTC) promotional labeling and advertisements for prescription drug and biologic products for ...
RAPS
1y

FDA drafts guidance on drug interaction labeling

The US Food and Drug Administration (FDA) has released a new draft guidance describing what should and should not be included in the Drug Interactions (DIs) section for human prescription drug and biological product labeling as well as how drug interaction ...
Cure Today
1y

The FDA Approves Labeling Update for Sandoz in the Treatment of B-Cell CLL

Project Renewal updates older oncology drug labels to ensure clinical relevance and scientific accuracy, involving external experts and early-career scientists. Fludarabine phosphate's updated label includes revised dosing regimens and moves a boxed ...
JD Supra
3y

FDA proposes mandatory patient labeling for Rx drugs - Proposed Patient Medication Information (PMI) is the latest in many efforts by FDA to mandate patient-directed labeling

Last week, the U.S. Food and Drug Administration (FDA) published the proposed rule “Medication Guides: Patient Medication Information,” which would significantly change the agency’s prescription drug product labeling regulations to require that Rx ...
RAPS
6y

FDA Drafts Two New Guidances on Drug Labeling

The US Food and Drug Administration (FDA) on Monday released one draft guidance on the content and format of the “Drug Abuse and Dependence” section of labeling and another on the content and format of the Instructions for Use (IFU) of a medicine.
TechJuice
3d

Government Approves Nationwide Track and Trace System for Medicines to Curb Fake Drugs

Pakistan approves a nationwide Track and Trace system for medicines to curb counterfeit drugs, improve drug safety, and enable digital verification across supply chain.
  • Privacy
  • Terms